Sellas Reports Promising AML Phase 2, Promising Ropeginterferon Boosts Blood Cancer Therapy, Cosmic Knots Reveal Matter Origins, Regeneron Drug Promises in MY Health, and more...

(0:10): SELLAS Life Sciences Reports Promising Phase 2 Results for AML Treatment at ASH 2025(2:33): AOP Health Showcases Promising Ropeginterferon Results for Blood Cancer Treatment at ASH Meeting(5:17): Japanese Physicists Propose Cosmic Knots Theory to Solve Matter Origin Mysteries(7:39): Regeneron's Lynozyfic Shows Promise as Frontline Therapy for Multiple Myeloma in LINKER Trials(10:11): Groundbreaking Study Maps Gut-Liver Pathway, Paving New Avenues for Diabetes and Obesity TreatmentTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: SSBCrack News